The ONC Jira Core and Confluence support team will soon implement an account deactivation policy for all users who have not logged into the systems within the previous 90-days or more. To avoid the risk of having your account being deactivated, please immediately log into ONC Jira Core and Confluence as soon as possible.
Accounts that are deactivated will be retained, including historic activity. Users are able to reactivate their accounts using the correct credentials used prior to deactivation. If a user has forgotten their usernames or passwords, they can email onc-jira-questions@healthit.gov to request reactivation.
Reminder: Do not include any PHI or PII in JIRA. If you require 508 accessibility assistance, then please send an email to onc-jira-questions@healthit.gov
Login Support: If you encounter a captcha prompt, login issues, or believe your account may be deactivated and require assistance, please send an email to onc-jira-questions@healthit.gov
If you have any further questions, comments or would like more information please contact ONCFASTLead:Alex.Kontur@hhs.gov
Image Removed
SME Session 7: Scaling Requirements for FHIR RESTful Exchange Intermediaries
This SME Panel Session will focus on the proposed solution to address barriers related to Scaling Architecture, developed by theFASTDirectory, Versions and Scale Tiger Team. The group of SMEs invited to participate in this session will be asked to evaluate the team's proposed solution, "Scaling Requirements for FHIR RESTful Exchange Intermediaries", and provide expert insight, feedback, and guidance.
Intermediaries will be needed to scale FHIR across a growing number of healthcare ecosystem participants in anticipation of future healthcare needs and increased transactions embedded in clinical workflows. Yet there are no “rules of the road” for intermediaries to meet minimum requirements for performance, availability, or response times in support of synchronous end-to-end real-time data exchange. The FAST team has proposed a solution intended to support:
The ability to utilize intermediaries to reduce the complexity of connecting with a large number of endpoints and managing authentication and authorization with each
Predictable intermediary performance to meet real-time exchanges
Participants
...
Vijey Kris Sridharan
...
*All SME participants with an asterisk by their name are invited, pending confirmation.
Scope and goals: This session is intended to orient SMEs to the work of FAST, the barriers this team is addressing and the proposed solution the team has developed. The goal is to provide SMEs with the foundational knowledge required to conduct an evaluation of the proposed solution prior to the SME Session.
Agenda
Introductions
FAST 101
SME Role and Expectations
Barriers & Proposed Solution
Setting the Stage for SME Session
MEETING MATERIALS COMING SOON!
Meeting #2 - SMEs Panel Session - An industry discussion around the FAST proposed solution for Scaling Requirements for FHIR RESTful Exchange Intermediaries (3 hours) (closed session, by invite only)
Date/time: 3-6PM ET
Scope and goals: The goal of this session is to elicit SMEs expert insight into proposed solution(s), specifically:
Feasibility and effectiveness
Potential gaps
Unintended consequences
Alternate approaches to consider
Industry path forward (standard, regulation or policy)
Agenda
Welcome
Session Goals
Solution Review and Discussion
Implications of Solution
Industry Path Forward
Action Items
MEETING MATERIALS COMING SOON!
Learn More About FAST
FAST’s goal is to analyze and identify HL7® Fast Healthcare Interoperability Resources (FHIR®) scalability gaps and offer possible solutions that will address current barriers and will accelerate FHIR adoption at scale.
To learn more, you can review theFASTAction Planfor a snapshot of the progress made byFASTso far.
Next Steps following SME Sessions
FAST Report-Out to summarize session discussion, decisions, and next steps
FAST Action Plan updates to define proposed solution path (standard, regulation and/or process)
Contact Us
If you have any further questions, comments or would like more information please contact ONCFASTLead:Alex.Kontur@hhs.gov